Fund Holdings — Prosight Management, LP

Total Portfolio Value:
$334.57M
Total Bought:
$107.60M
Total Sold:
$78.91M
Net Transaction:
+$28.69M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Lakefront Biotherapeutics NVADR(LKFT)931,5121,349,980+418,468$29.99M$33.45M10.00%+$3.46M
ADC Therapeutics SASHS(ADCT)7,050,3009,570,000+2,519,700$31.66M$30.24M9.04%-$1.41M
Roivant Sciences Ltd.SHS(ROIV)1,860,0002,000,000+140,000$19.60M$21.14M6.32%+$1.54M
BridgeBio Pharma, Inc.(BBIO)589,530800,000+210,470$18.23M$20.26M6.06%+$2.04M
Zimmer Biomet Holdings, Inc.(ZBH)18,908170,000+151,092$2.50M$18.45M5.51%+$15.95M
MeiraGTx Holdings plc(MGTX)4,017,3014,352,700+335,399$24.39M$18.32M5.48%-$6.06M
Shattuck Labs, Inc.(STTK)3,725,0004,670,000+945,000$33.30M$18.03M5.39%-$15.28M
Kura Oncology, Inc.(KURA)960,000629,900-330,100$20.48M$12.97M3.88%-$7.51M
Cytokinetics, Incorporated(CYTK)245,000230,000-15,000$17.18M$12.46M3.72%-$4.72M
Syndax Pharmaceuticals, Inc.(SNDX)0551,544+551,544$0$11.32M3.38%+$11.32M
Mirum Pharmaceuticals, Inc.(MIRM)465,000314,800-150,200$11.68M$10.76M3.22%-$917.8K
Kelly Services, Inc.CL A(KELYA)348,686492,340+143,654$8.73M$10.54M3.15%+$1.81M
Zymeworks Inc.(ZYME)410,9481,180,000+769,052$4.32M$10.04M3.00%+$5.72M
Immunovant, Inc.(IMVT)195,000325,000+130,000$6.30M$8.58M2.56%+$2.28M
Schrödinger, Inc.(SDGR)0369,261+369,261$0$7.14M2.13%+$7.14M
AbCellera Biologics Inc.(ABCL)1,790,0002,352,633+562,633$8.11M$6.96M2.08%-$1.14M
Alkermes plcSHS(ALKS)215,000275,000+60,000$5.82M$6.63M1.98%+$807.5K
Erasca, Inc.(ERAS)3,659,7552,750,000-909,755$7.54M$6.49M1.94%-$1.05M
Viking Therapeutics, Inc.(VKTX)39,046115,000+75,954$3.20M$6.10M1.82%+$2.89M
Prothena Corp PlcSHS
SHS
170,469286,926+116,457$4.22M$5.92M1.77%+$1.70M
OrthoPediatrics Corp.(KIDS)418,261200,216-218,045$12.20M$5.76M1.72%-$6.44M
Option Care Health, Inc.(OPCH)100,000205,000+105,000$3.35M$5.68M1.70%+$2.32M
DexCom, Inc.(DXCM)23,00049,317+26,317$3.19M$5.59M1.67%+$2.40M
Accolade Inc01,489,525+1,489,525$0$5.33M1.59%+$5.33M
Cogent Biosciences, Inc.(COGT)555,500500,000-55,500$3.73M$4.21M1.26%+$482.0K
Neurocrine Biosciences, Inc.(NBIX)30,50027,000-3,500$4.21M$3.72M1.11%-$489.5K
Relay Therapeutics, Inc.(RLAY)450,000385,000-65,000$3.73M$2.51M0.75%-$1.22M
BioCryst Pharmaceuticals, Inc.(BCRX)1,400,000398,700-1,001,300$7.11M$2.46M0.74%-$4.65M
CVS Health Corporation(CVS)040,000+40,000$0$2.36M0.71%+$2.36M
Medtronic plcSHS(MDT)180,00030,000-150,000$15.69M$2.36M0.71%-$13.33M
Vincerx Pharma Inc02,488,418+2,488,418$0$2.02M0.60%+$2.02M
Inspire Medical Systems, Inc.(INSP)014,000+14,000$0$1.87M0.56%+$1.87M
Paragon 28 Inc0261,400+261,400$0$1.79M0.53%+$1.79M
Universal Health Services, Inc.CL B(UHS)30,0009,373-20,627$5.47M$1.73M0.52%-$3.74M
Privia Health Group, Inc.(PRVA)45,00096,065+51,065$881.5K$1.67M0.50%+$788.1K
Mural Oncology Pub Ltd Co400,000475,458+75,458$1.96M$1.49M0.45%-$463.1K
Addus Homecare Corp012,500+12,500$0$1.45M0.43%+$1.45M
Tectonic Therapeutic, Inc.(TECX)067,461+67,461$0$1.11M0.33%+$1.11M
LENZ Therapeutics, Inc.(LENZ)65,00059,542-5,458$1.45M$1.03M0.31%-$422.0K
10x Genomics, Inc.CL A(TXG)30,00049,021+19,021$1.13M$953.5K0.28%-$172.4K
Ovid Therapeutics Inc.(OVID)983,2001,075,000+91,800$3.00M$826.9K0.25%-$2.17M
Immunome, Inc.(IMNM)065,000+65,000$0$786.5K0.24%+$786.5K
Rein Therapeutics Inc.(RNTX)0265,000+265,000$0$734.0K0.22%+$734.0K
Immuneering CorpCL A0550,000+550,000$0$704.0K0.21%+$704.0K
Biomea Fusion, Inc.(BMEA)75,000124,377+49,377$1.12M$559.7K0.17%-$561.6K
Kezar Life Sciences Inc963,59856,080-907,518$868.8K$33.6K0.01%-$835.1K
Absci Corporation25,0000-25,000$142.0K$0—-$142.0K
Agios Pharmaceuticals, Inc.(AGIO)25,0000-25,000$731.0K$0—-$731.0K
Avrobio Inc566,5190-566,519$725.1K$0—-$725.1K
Barrett Business Svcs Inc24,0000-24,000$3.04M$0—-$3.04M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)100,6170-100,617$3.95M$0—-$3.95M
Guardant Health, Inc.(GH)470,0000-470,000$9.70M$0—-$9.70M
Maravai LifeSciences Holdings, Inc.CL A(MRVI)599,4600-599,460$5.20M$0—-$5.20M
Nuvation Bio Inc.CL A(NUVB)250,0000-250,000$910.0K$0—-$910.0K
Pacira BioSciences, Inc.(PCRX)94,3620-94,362$2.76M$0—-$2.76M
Pfizer Inc.(PFE)215,0000-215,000$5.97M$0—-$5.97M
Page 1 of 1
Prosight Management, LP — 13F Holdings — Q2 2024 | TickerTrail